Patten & Patten’s GSK GSK Stock Holding History

Patten & Patten’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-3,186	Closed	-$213K	–	266
2013 Q4	$213K	Buy	+3,186	New	+$207K	0.03%	236

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Patten & Patten's GSK Position: Q1 2014 in Review

Patten & Patten sold out of GSK (GSK) in Q1 2014, closing a stake of 3,186 shares — an estimated $213K sold.

Patten & Patten first reported a position in GSK in Q4 2013 and held it in 1 quarter. The position peaked at $213K in Q4 2013. 712 funds tracked by Wall St. Rank hold GSK as of Q1 2014.

Patten & Patten reported no remaining GSK position as of Q1 2014 after selling out during the quarter.
Patten & Patten sold 3,186 GSK shares in Q1 2014, an estimated $213K.
Patten & Patten first reported a position in GSK in Q4 2013 and held it in 1 quarter.
Patten & Patten's GSK position peaked at $213K in Q4 2013.
712 funds tracked by Wall St. Rank held GSK as of Q1 2014.

Based on Patten & Patten's 13F filing for Q1 2014, filed 24 Apr 2014.